Pharmacogenomics: Identification of New Drug Targets
Cystic Fibrosis: Pathogenesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Joana Almaça1, Shehrazade Dahimène, Nicole Appel
1Faculty of Sciences, BioFiG-Centre for Biodiversity and Functional and Integrative Genomics, University of Lisboa, Lisboa, Portugal. jcalmaca@fc.ul.pt
New strategies identify key gene products causing cystic fibrosis (CF) cellular defects. High-content screens assess proteins impacting CFTR and ENaC function and trafficking for better CF pathophysiology understanding and targeted therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: